Anti-Parkinsonian Drugs and Neuroleptics Flashcards

1
Q

Describe DA synthesis

A
  • L-tyrosine -> (tyrosine hydroxylase) ->L-DOPA -> (DOPA decarboxylase) -> Dopamine (DA)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the rate limiting step in DA synthesis

A

Tyrosine hydroxylase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What removes DA from the synapse (2)

A

DA transporter and NA transporter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What metabolises DA (3)

A

Monoamine oxidase A (MAO-A) - metabolises DA, NE & 5-HT
MAO-B - metabolises DA
Catechol-O-methyl transferase (COMT) - wide distribution (glial cell, presynaptic terminal, CM of other cells), metabolises all catecholamines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What enzymes metabolises all catecholamines

A

COMT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What does MAOA metabolise?

A

DA, NE, 5-HT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

4 major dopaminergic pathways?

A
  1. Nigrostriatal pathway - susbstantia nigra pars compacta (SNc) to the striatum Inhibition results in movement disorders (Parkinsons)
  2. Mesolimbic pathway - ventral tegmental area (VTA) to the Nucleus Accumbens (NAcc) Brain reward pathway (Schizophrenia)
  3. Mesocortical pathway - VTA to the cerebrum/frontal lobe. Important in executive functions & complex behavioural patterns (Schizophrenia)
  4. Tuberoinfundibular pathway - arcuate nucleus to the median eminence. Inhibition results in hyperprolactinaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Where is Nigrostriatal pathway from/to

A

susbstantia nigra pars compacta (SNc) to the striatum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does inhibition of the Nigrostriatal pathway result in

A

Movement disorders (Parkinsons)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Where is Mesolimbic pathway from/to

A

ventral tegmental area (VTA) to the Nucleus Accumbens (NAcc)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Where is mesocortical pathway from/to

A

VTA to the cerebrum/frontal lobe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Where is tuberoinfundibular pathway from/to

A

arcuate nucleus to the median eminence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the pathway from susbstantia nigra pars compacta (SNc) to the striatum known as

A

Nigrostriatal pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the pathway from arcuate nucleus to the median eminence known as

A

tuberoinfundibular pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the pathway from VTA to the cerebrum/frontal lobe known as

A

mesocortical pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the pathway from ventral tegmental area (VTA) to the Nucleus Accumbens (NAcc) known as

A

Mesolimbic pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What does inhibition of the susbstantia nigra pars compacta (SNc) pathway to the striatum lead to

A

Movement disorders (Parkinsons)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What does dysfunction of the Mesolimbic pathway lead to

A

Schizophrenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What does dysfunction of the mesocortical pathway lead to

A

Schizophrenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What does dysfunction of the tuberoinfundibular pathway lead to

A

hyperprolactinaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What does pathway dysfunction of ventral tegmental area (VTA) to the Nucleus Accumbens (NAcc) lead to

A

Schizophrenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What does pathway dysfunction of VTA to the cerebrum/frontal lobe lead to

A

Schizophrenia

23
Q

What does pathway dysfunction of susbstantia nigra pars compacta (SNc) to the striatum lead to

A

Parkinsons and other motor diseases

24
Q

What is the Mesocortical pathway important for

A

executive functions & complex behavioural patterns

25
What is the mesolimbic pathway important for
Brain reward pathway
26
Difference in causes of early and late stage onset of Parkinsons
Only early stage has genetic associations
27
Similarity between Alzheimers and Parkinsons regarding their onset?
Only early stage has genetic associations
28
Pathophysiology of Parkinsons? (loss of what where, what is found to be present/abnormal)
- Severe loss of dopaminergic projection cells in SNc – nigrostriatal pathway - Lewy bodies & neurites -> Found respectively within neuronal cell bodies & axons - Consist of abnormally phosphorylated neurofilaments, ubiquitin & a-synuclein
29
Motor symptoms of Parkinsons?
resting tremor, bradykinesia (slowness in movement), rigidity, postural instability (cardinal symptoms) (4)
30
ANS deficits of Parkinson's? (3)
olfactory deficits, orthostatic hypotension, constipation
31
Neuropsychiatric presentations of Parkinsons?
sleep disorders, memory deficits, depression, irritability
32
3 Main methods of treating Parkinsons?
1. Dopamine replacement 2. Dopamine receptor agonists 3. Monoamine oxidase B (MAOB) inhibitors
33
Adjuncts given alongside DA replacements?
DOPA decarboxylase inhibitors | COMT inhibitors
34
Example of dopamine replacement?
L-DOPA
35
Side effects (short and long term) of DA replacement?
ST: nausea & vomiting LT: dyskinesias & ‘on-off’ effects
36
How does L-DOPA work?
- Rapidly converted to DA by DOPA decarboxylase (DOPA-D) - Can cross blood-brain barrier (BBB) - Basically works by flooding the remaining neurons that have survived the neurodegeneration with dopamine which acts on the D2 receptor D2R. - Peripheral breakdown by DOPA-D ® Leads to activation of the CTZ chemoreceptor trigger zone and so nausea & vomiting
37
Purpose of DOPA decarboxylase inhibitors given as adjuncts with L-DOPA?
does not cross BBB -> prevents peripheral breakdown of levodopa and then separates with it at the BBB Reduces levodopa dosage needed
38
Receptors that L-DOPA activates post-cleavage?
- Dopamine (DA) can act on D1,5(Gs linked) or D2-4 (Gi-linked) receptors - DA is re-uptaken by the dopamine transporter (DAT) & metabolised by monoamine oxidase (MAO) enzymes
39
problem with DA receptor agonists? (which type of DA agonist?)
- Associated with cardiac fibrosis | Ergot derivatives
40
Which type of DA receptor agonist is associated with cardiac fibrosis and which one isn't
Ergot derivatives are | Non-ergot aren't
41
Life expectancy of schizophrenics?
30 years less than usual
42
Predisposing factors of schizophrenia
Genetics and afro-carribeans
43
What is the reason for the different life expectancy of schizophrenics?
recreational drug use to alleviate symptoms kills people early
44
'Positive' symptoms of schizophrenia (4)
- Increased Mesolimbic dopaminergic activity - Hallucinations- Auditory & visual - Delusions- Paranoia - Thought disorder- Denial about oneself
45
'Negative' symptoms of schizophrenia? (4)
- Decreased Mesocortical dopaminergic activity - Affective flattening- lack of emotion - Alogia- lack of speech - Avolition/apathy- loss of motivation
46
Most effective antipsychotic?Why is it the most effective?
Clozapine as it treats both positive and negative symptoms of schizophrenia
47
second gen antipsychotic examples? (3)
Clozapine, risperidone, quetiapine
48
quetiapine e.g. of?
Second gen antipsychotic
49
risperidone e.g. of?
Second gen antipsychotic
50
Clozapine e.g. of?
Second gen antipsychotic
51
Antipsychotic receptor targets?
5-HT, D2 receptors, H1 receptors
52
MOA of clozapine
- Very potent antagonist of 5-HT2A receptors
53
MOA of risperidone
5HT and D2 antagonist
54
MOA of quetiapine
Potent H1 antagonist